Sonoma Pharmaceuticals, Inc. SNOA
1.24 USD +0.10 (+8.77%)
At closeNov 11, 2026, 4:00 PM EST
1.24 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
1.18 Day range 1.30
1.01 52-week range 3.80
- YTD
- -65.93%
- 1 year
- -66.84%
News
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) stock increased by 13.2% to $1.29 during Wednesday's pre-market session. The company's market cap stands at $5.4 million. The company's, Q2 earnings came…
benzinga.com Sonoma Pharmaceuticals Q2 EPS $(0.01) Up From $(0.32) YoY, Sales $7.174M Up From $5.604M YoY Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.01) per share. This is a 96.88 percent increase over losses of $(0.32) per share from the same period last year. The company…
defenseworld.net Orion OYJ (OTCMKTS:ORINY) & Sonoma Pharmaceuticals (NASDAQ:SNOA) Head to Head Contrast Orion OYJ (OTCMKTS:ORINY - Get Free Report) and Sonoma Pharmaceuticals (NASDAQ: SNOA - Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two…
defenseworld.net Financial Contrast: Sonoma Pharmaceuticals (NASDAQ:SNOA) versus Indivior (NASDAQ:INDV) Sonoma Pharmaceuticals (NASDAQ: SNOA - Get Free Report) and Indivior (NASDAQ: INDV - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two…
defenseworld.net Sonoma Pharmaceuticals (NASDAQ:SNOA) & Harmony Biosciences (NASDAQ:HRMY) Critical Analysis Harmony Biosciences (NASDAQ: HRMY - Get Free Report) and Sonoma Pharmaceuticals (NASDAQ: SNOA - Get Free Report) are both healthcare companies, but which is the better business? We will compare the…
accessnewswire.com Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA Total revenue increased 60% year over year to $6.4 million Net loss per share decreased 88% compared to the prior-year quarter Gross margin expanded to 40% as operating expenses remained stable FDA…
benzinga.com Sonoma Pharmaceuticals Q1 EPS $(0.09) Up From $(0.76) YoY, Sales $6.406M Up From $4.015M YoY Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.09) per share. This is a 88.16 percent increase over losses of $(0.76) per share from the same period last year. The company…
benzinga.com Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) on Thursday posted a first-quarter loss of 9 cents per share compared to a loss of 76 cents a year ago.
benzinga.com Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue Sonoma Pharmaceuticals reported record Q1 revenue, narrow loss, doubled U.S. sales and achieved positive adjusted EBITDA for the first time.
benzinga.com Sonoma Pharmaceuticals Receives FDA 510(k) Clearance For Its Microdacyn Wound Irrigation Solution Clearance includes expanded claims, clearance for multiple use, and additional packaging configurations.Under this new clearance, Microdacyn Wound Irrigation Solution can be used under the…
accessnewswire.com Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced it has received a new…- benzinga.com Sonoma Pharmaceuticals Q4 EPS $(0.33) Misses $(0.24) Estimate, Sales $5.561M Miss $5.565M Estimate Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.24) by 37.5 percent. This is a 31.25 percent increase over…
accessnewswire.com Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results Revenues increased 48% in Q4 2026 compared to Q4 2025, and 37% in FY 2026 compared to FY 2025 United States revenues increased 194% in Q4 2026 compared to Q4 2025 and 117% in FY 2026 compared to FY…
benzinga.com What's Going On With Sonoma Pharma Stock Monday? Sonoma Pharmaceuticals (SNOA) shares slide following a $4M public offering priced at $1.35. Get the latest stock news here.
defenseworld.net Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Short Interest Update Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA - Get Free Report) was the recipient of a significant decrease in short interest during the month of April. As of April 15th, there was short interest…
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com Dow Falls Over 150 Points; Procter & Gamble Posts Upbeat Earnings 
benzinga.com Nasdaq Gains Over 100 Points; Intel Shares Jump After Strong Q1 Results US stocks mixed, Nasdaq up 100pts. Dow down 0.35%, Nasdaq up 0.56%, S&P 500 up 0.19%. Tech up 1.1%, healthcare down 1.1%. Intel up 23% on strong earnings.
benzinga.com Sonoma Pharmaceuticals Prices Offering Of 2,962,963 Shares And Accompanying Warrants At $1.35 Per Unit Sonoma Pharmaceuticals, Inc. (the "Company" or "Sonoma Pharmaceuticals") (NASDAQ: SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced the pricing of its public…
accessnewswire.com Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering BOULDER, CO / ACCESS Newswire / April 24, 2026 / Sonoma Pharmaceuticals, Inc. (the "Company" or "Sonoma Pharmaceuticals") (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl)…- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
feeds.benzinga.com Sonoma Pharmaceuticals (SNOA) Jumps 16% After Hours On Burn Relief Hydrogel Launch In Walmart, CVS Sonoma Pharmaceuticals jumps over 16% in after-hours trading following the U.S. retail launch of its burn relief hydrogel in CVS and Walmart stores.
benzinga.com Sonoma Pharmaceuticals (SNOA) Jumps 16% After Hours On Burn Relief Hydrogel Launch In Walmart, CVS Sonoma Pharmaceuticals jumps over 16% in after-hours trading following the U.S. retail launch of its burn relief hydrogel in CVS and Walmart stores.
accessnewswire.com Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart BOULDER, CO / ACCESS Newswire / March 24, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced the U.S. retail launch…
accessnewswire.com Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin BOULDER, CO / ACCESS Newswire / March 18, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized…
accessnewswire.com Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended December 31, 2025 compared to prior year Net loss and net loss per share decreased from prior year for…
accessnewswire.com Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development BOULDER, CO / ACCESS Newswire / January 28, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized…
defenseworld.net Head to Head Comparison: Ocular Therapeutix (NASDAQ:OCUL) & Sonoma Pharmaceuticals (NASDAQ:SNOA) Sonoma Pharmaceuticals (NASDAQ: SNOA - Get Free Report) and Ocular Therapeutix (NASDAQ: OCUL - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two…
defenseworld.net Sonoma Pharmaceuticals (NASDAQ:SNOA) Share Price Passes Above 200-Day Moving Average – Time to Sell? Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average…
accessnewswire.com National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized…
accessnewswire.com Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf BOULDER, CO / ACCESS Newswire / November 6, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized…
accessnewswire.com Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results Revenues increased 57% for the quarter and 38% for the six months ended September 30, 2025 compared to same periods last year U.S. revenue increased 115% for the quarter and 86% for the six months…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
accessnewswire.com Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals BOULDER, CO / ACCESS Newswire / October 14, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader in developing and producing stabilized hypochlorous acid (HOCl) products…
benzinga.com 5 Healthcare Stocks On Fire This Week Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech & pharma.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Dow Falls Over 100 Points; Deere Shares Dip After Q3 Results 
benzinga.com Why Xos Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results 
benzinga.com Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket 
benzinga.com Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session